Authors


Ali McBride, PharmD, MS

Latest:

5-HT3 Receptor Antagonist Effects in Cancer Patients With Multiple Risk Factors

Palonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.


Brian Larson, BS Pharm, RPh

Latest:

Preparing for New Rules on Hazardous Drug Management

Many clinicians have been preparing for USP for a long time and are well on their way to compliance.


Aislinn Antrim, Assistant Editor

Latest:

Study: Intravenous Immunoglobulin Hastens Recovery of Early Onset Guillain-Barre

If IVIG is commenced within 2 weeks from the onset of Guillain-Barre syndrome it can hasten recovery as much as plasma exchange, study indicates.


Dana P. Goldman, PhD

Latest:

Patient Preference for Treatment Administration in Cystic Fibrosis

This study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.



Laura Regan

Latest:

Part Two: Influential Women in Specialty Pharmacy Help Guide the Industry

The second half of a 2-part series on the influential women shaping the specialty pharmacy industry.


Doug Zurawski, PharmD

Latest:

How to Leverage the Revised ASHP Guidelines to Prevent the Diversion of Controlled Substances at Hospitals

A controlled substances diversion prevention program (CSDPP) that aligns with the revised ASHP guidelines is critical to ensure patients are protected from occurrences of drug diversion.


Catherine I. Starner, PharmD, BCPS

Latest:

A Linezolid Prior Authorization Program: Clinical and Economic Outcomes

This study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.


Anthony Palmieri, RPh, PharmD, MBA

Latest:

Trends in Statin Treatment Costs and Potential Impact of Novel Therapies

Generic atorvastatin led to an increase in generic dispensing rate and a reduction in the cost of treatment for patients requiring cholesterol-lowering treatment. The upcoming introduction of the PCSK9 inhibitor may change this trend.


Abimbola Farinde, PhD, PharmD

Latest:

Pharmacists Can Be Invaluable in Identifying Chest Pain

Help patients choose appropriate medications and direct them to a physician, when necessary


Sue Geraghty, RN, MBA

Latest:

Hemophilia and Managed Care: Partnering to Achieve Cost-Effective Care

Exploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.


Matthew Savoie, PharmD

Latest:

Neuropathic Pain: A Glimpse Inside the Unabating Affliction

Originating from damage within nerve cells themselves, neuropathic pain is often complex, with many treatment challenges.


Katherine E. MacDonald

Latest:

Be Vigilant With Pediatric Populations

Clinicians often reserve vigilance with drug-related issues for critically ill patients or older populations, while mistaking the resilience of childhood as a protective barrier.


Alex Evans, PharmD, BCGP

Latest:

4 Pharmacy Operations Missteps to Avoid

While not everything on this list is a law, they are all at least best practices and/or tips to most efficiently comply with a law or regulation, and to get your job done.



Sagar Shah

Latest:

Consider New Treatment Options for COPD

Pharmacists should familiarize themselves with these therapies to help patients lessen the risk of emergency department visits and hospitalizations.


Emily V. Olivier, PharmD Candidate

Latest:

Lung Cancers: Facts, Causes, and Types

In 2017, lung cancer is projected to be the second most prevalent type of cancer in the United States, with about 222,500 new cases and is estimated to still be the leading cause of cancer-related death, with 155,870 deaths.


Laura Cranston, RPh

Latest:

Emerging Trends in Adherence and Quality Measurement: What the Future Holds

Adherence measurement can help patients achieve better outcomes.



John Collins, MD

Latest:

The Comparative Value of 3 Electronic Sources of Medication Data

Combining medication history information from multiple sources improves the completeness and accuracy of the medication information.


Ezimma Nnyagu, PharmD Candidate

Latest:

Improve Medication Adherence in Patients with HIV

Pharmacists can motivate patients to stick to their drug regimens to decrease viral load and prevent further transmission.



Joseph K. Jordan, PharmD, BCPS

Latest:

Medication Formulary Management in a Large, Multihospital System

Clarian Health, an 11-hospital health system, developed and managed a multihospital formulary through focused planning and collaboration.


Shivangi Patel, PharmD Candidate

Latest:

Short-Term and Long-Term Impact of COVID-19 on Community Pharmacy

Whether it be delivery options, remote pharmacy, increasing roles for pharmacists and technicians, or fluctuating patient volume, the impact of COVID-19 can be felt in community pharmacies across the United States.


Nina Elk, PharmD, BCPS

Latest:

Hybrid Models Can Transform Team Chemistry

Morristown Medical Center’s area-based pharmacist program leads to an increase in direct patient contact and opportunities for interventions.


Jason Broderick

Latest:

Combination Shows Promise for Treating Advanced Non Small Cell Lung Cancer

Combining pegilodecakin (AM0010) with nivolumab (Opdivo) or pembrolizumab (Keytruda) induced an overall response rate (ORR) of 41% in patients with advanced non–small cell lung cancer (NSCLC), according to findings from an early phase study presented at the 2018 ASCO Annual meeting.


Lisa E. Hines, PharmD

Latest:

A Population-Based Approach to Improving Patient Safety Related to Drug—Drug Interactions

Some medication combinations are a source of preventable drug-related harm. A multifaceted approach is needed to address this quality-of-care issue.


Mihir H. Patel, PharmD

Latest:

Determinants of Primary Nonadherence in Asthma-Controller and Dyslipidemia Pharmacotherapy

This study linked e-prescribing records to paid pharmacy claims to identify primary nonadherence rates and factors associated with unfilled prescriptions.